Work

Supplemental Figure S1 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Therapeutic efficacy of αTRP1 combined with two doses of cyclophosphamide (CY) in established melanoma.

DOI: 10.1158/2326-6066.22538861.v1

Authors: Marina Moskalenko, Michael Pan, Yichun Fu, Ellen H. de Moll, Daigo Hashimoto, Arthur Mortha, Marylene Leboeuf, Padmini Jayaraman, Sebastian Bernardo, Andrew G. Sikora, Jedd Wolchok, Nina Bhardwaj, Miriam Merad, Yvonne Saenger

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362540504

Cites:

Cited by:

Related to: 10